Concepedia

Stephanie Loewen

SL

Statistics

Publications

6

Citations

197

H-Index

6

Active since

2018

Affiliations

Bayer (Germany)(Current)

Stephanie Loewen is an author at Bayer (Germany) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

2018–2022

6

Publications

6

Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects

Michael Böettcher, Dirk Thomas, Wolfgang Mueck et al. · European Journal of Clinical Pharmacology · 2020 · 72 citations · Full text

, , +14

Pharmacokinetics of the Novel, Selective, Non-steroidal Mineralocorticoid Receptor Antagonist Finerenone in Healthy Volunteers: Results from an Absolute Bioavailability Study and Drug–Drug Interaction Studies In Vitro and In Vivo

Roland Heinig, Michael Gerisch, Anna Engelen et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2018 · 45 citations

, , +7

Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers

Michael Böettcher, Stephanie Loewen, Mireille Gerrits et al. · Clinical Pharmacokinetics · 2020 · 31 citations · Full text

, , +17

Results from Drug–Drug Interaction Studies In Vitro and In Vivo Investigating the Effect of Finerenone on the Pharmacokinetics of Comedications

Roland Heinig, Michael Gerisch, Michaela Bairlein et al. · European Journal of Drug Metabolism and Pharmacokinetics · 2020 · 19 citations

, , +11

Determination of finerenone – a novel, selective, nonsteroidal mineralocorticoid receptor antagonist – in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study in venous and capillary human plasma

Gabriele Rohde, Stephanie Loewen, Roland Heinig · Journal of Chromatography B · 2021 · 19 citations

, , +14

1–5 of 6